Clinical Trials Directory

Trials / Sponsors / Direct Biologics, LLC

Direct Biologics, LLC

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingDB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
Perianal Fistula Due to Crohn's Disease
Phase 22025-05-19
WithdrawnBone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS
ARDS, Human
Phase 1 / Phase 22024-12-01
WithdrawnExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome
Covid19, Postviral Syndrome, Dyspnea
Phase 1 / Phase 22024-11-01
TerminatedStudy of ExoFlo for the Treatment of Perianal Fistulas
Perianal Fistula, Crohn's Disease
Phase 1 / Phase 22023-08-28
TerminatedStudy of ExoFlo for the Treatment of Medically Refractory Crohn's Disease
Crohn Disease, Inflammatory Bowel Diseases
Phase 12023-01-23
TerminatedStudy of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
Ulcerative Colitis, Inflammatory Bowel Diseases
Phase 12022-12-19
WithdrawnExtracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
COVID-19
Phase 22022-12-07
RecruitingExtracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 32022-07-01
CompletedExtracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
COVID-19, ARDS
Phase 22020-09-24
No Longer AvailableExpanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection
——
No Longer AvailableExpanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
Covid19, ARDS, Hypoxia
——